Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: -0.50 (-0.76%)
Spread: 4.00 (6.349%)
Open: 65.50
High: 65.50
Low: 65.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

19 Sep 2006 07:01

Torex Retail PLC19 September 2006 Torex Retail plc: Board Changes Announces appointment of new Chief Executive Officer Torex Retail plc, the leading supplier of IT solutions to retailers worldwide,today announces the appointment of Neil Mitchell as new Chief Executive Officerwith immediate effect. In addition, it also announces that Marcus Leek has been promoted to the mainplc board as Group Finance Director with immediate effect. Chris Moore, Chairman and Chief Executive will be stepping down from the role ofChief Executive but will move to Non-Executive Chairman with an operational rolefocused on the continued development of, and liaison with, global retailcustomers. An executive search has been instituted to identify a suitable Non-ExecutiveChairman for the Group. The role is being undertaken by Chris for an interimperiod until the successful outcome of the executive search and a properhand-over can be achieved. At that time, Chris will remain with the businessperforming an advisory customer-focused role. Neil Mitchell, aged 42, has accepted the role of Chief Executive Officer. Neilhas considerable experience working in business and strategic planning for majorUK and international companies. He was most recently Executive Chairman of aspecialist international corporate advisory group dealing in strategydeployment, international trade and specific post M&A business transformation.Having been an integral part of project teams, Neil has executed corporatetransactions in selected sectors across Europe, USA, South America and Russianmarkets. After an earlier career at BAe Systems and in management consultancy with IBMGlobal Services, from 1996 - 2000 Neil worked as special adviser to variousentertainment & media technology companies in Hollywood, energy companies in theUSA and with two UK listed companies, United Utilities Plc and Severn Trent Plc,where he worked on corporate transformation plans, strategy and businessplanning, innovative new venture creation and international businessdevelopment. A key achievement during this period was as strategic advisor toSevern Trent's Group Chief Executive where he was the architect and developer ofthe USA strategy and operational plan for Severn Trent Services Inc. to growrevenues from US$200m to US$1bn achieved through restructuring, customer serviceimprovements and major operating efficiency gains. Commenting on his appointment, Neil Mitchell said: "I am absolutely delighted tobe joining Torex Retail at such an exciting time in its corporate development:my experience of strategic business management is highly relevant to the groupas it emerges from a high level of M&A into a platform poised for significantorganic growth." "Torex Retail has a global market position of scale in retail IT solutions, anestablished blue chip customer base, and the opportunity to exploit the growthprofile of the sector. Our challenge will be to ensure that we achieve sustainedgrowth through excellent customer service delivery, for the benefit of allstakeholders." - Ends - Enquiries: Citigate Dewe Rogerson:Ginny Pulbrook, Director Tel: 020 7282 2945Seb Hoyle, Associate Director Tel: 020 7282 2882 Save as disclosed below, there is nothing further to disclose in relation toNeil Mitchell or Marcus Leek's appointment under schedule two, paragraph (g) ofthe AIM Rules. Neil Mitchell: Past directorships: Mackie Wood Mitchell Limited MWM International Limited Cornish Spring Water Co Limited Magic Dimensional Images Limited Marcus Leek: Past directorships: Bells Stores Limited 4u Business Limited Notes to Editors: About Torex Retail Plc Torex Retail is a leading independent provider of innovative retail technologysolutions to many of the world's principal retailers. Since the company'sflotation in spring 2004 Torex Retail has achieved rapid growth across all ofits markets and has rigorously pursued its goal of becoming the provider ofchoice. As a result, the company now has a presence in all of the major marketsaround the world and has built a strong platform for future growth in line withits strategy. Torex's Retail's product and solution set spans high street andout-of-town retail as well as hospitality and the petroleum and conveniencesector. With over 6,000 customer relationships, including McDonalds, Tesco,Woolworth, Selfridges, Shell and Argos, the company has earned a leadingreputation amongst retailers. Torex Retail has more than 2,800 staff based in 17countries. www.torexretail.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Nov 20197:00 amRNSUpdate in relation to loan facility
17th Oct 20194:27 pmRNSHolding(s) in Company
17th Oct 20197:00 amRNSTrading Update
15th Oct 20193:27 pmRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDermaPure Product Line Extension Launched
10th Sep 20197:00 amRNSUnaudited Interim Results
28th Aug 20197:00 amRNSAppointment of CFO
15th Aug 20197:00 amRNSAdditional manufacturing capacity secured
1st Aug 20197:00 amRNSDirectorate Change
8th Jul 20195:03 pmRNSHolding(s) in Company
20th Jun 20192:23 pmEQSHardman & Co Research: Tissue Regenix (TRX): Credit facilities expand cash runway to 2021
7th Jun 20192:55 pmRNSIssue of Equity and Total Voting Rights
4th Jun 20197:00 amRNSNotice of AGM
4th Jun 20197:00 amRNSSecures Credit Facilities of up to $20m
4th Jun 20197:00 amRNSAnnual Results for the year ended 31 December 2018
21st May 20197:00 amRNSCEO to return to full time duties
10th Apr 20197:20 amEQSHardman & Co Research: Tissue Regenix (TRX): Expanded GPO coverage secured
4th Apr 20197:26 amRNSExpands US GPO coverage for DermaPure
18th Feb 20197:00 amRNSChange of Adviser
6th Feb 201911:05 amRNSSecond Price Monitoring Extn
6th Feb 201911:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSTrading Update
17th Dec 201811:56 amEQSHardman & Co Research: Tissue Regenix (TRX): 2018 in review: foundations laid for osteobiologics
6th Dec 20187:00 amRNSInterim Management Change
13th Nov 20187:00 amRNSPan European distribution agreement with Arthrex
29th Oct 20187:00 amRNSGareth Jones commences position as CFO
14th Sep 20187:16 amEQSHardman & Co Research: Tissue Regenix (TRX): Strategy delivering growth above expectations
3rd Sep 20187:00 amRNSUnaudited Interim Results
2nd Aug 201810:10 amEQSHardman & Co Research: Tissue Regenix (TRX): 1H'18 preview: organic plus inorganic growth
2nd Aug 20187:00 amRNSNotice of Interim Results
4th Jul 20187:00 amRNSAppointment of CFO
25th Jun 20187:00 amRNSHTA License granted and UK distribution Agreement
21st Jun 20187:10 amRNSTRX BioSurgery wins GPO Supplier Horizon Award
18th Jun 20187:00 amRNSIssue of Equity
24th May 201812:12 pmRNSResult of AGM
2nd May 20187:00 amRNSTRX BioSurgery GPO agreement with Premier, Inc.
27th Apr 20187:00 amRNSPosting of Annual Report and Notice of AGM
24th Apr 20187:00 amRNSDermaPure manufacturing at CellRight Facility
19th Apr 20183:29 pmRNSHolding(s) in Company
5th Apr 20187:17 amEQSHardman & Co Research: Tissue Regenix (TRX): CellRight hits the right note
26th Mar 20187:00 amRNSAnnual results for period ended 31 December 2017
16th Mar 20183:40 pmRNSPublication of Financial Results
8th Mar 20187:15 amRNSHardman & Co: Full-year 2017 - what to look for
6th Mar 20187:00 amRNSLong term distribution agreement with Arthrex, Inc
26th Feb 20187:00 amRNSNotice of Results
26th Feb 20187:00 amRNSLaunch of BioSurgery and new distributor agreement
2nd Feb 20187:00 amRNSIssue of Equity
22nd Dec 20179:30 amRNSIssue of Equity
1st Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.